Role of ROS and cAMP-PKA Biomarkers in ADPKD (NCT07217158)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Mayo Clinic — Rochester, Minnesota

📞 Contact the Study Coordinator

Phone: (800) 664-4580

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Autosomal Dominant Polycystic Kidney Disease

• Intrarenal Microvasculature in ADPKD — Rochester, Minnesota
• A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD — Rochester, Minnesota
• NOX4 and Related Biomarkers in ADPKD — Rochester, Minnesota
• Managing Depressive Symptoms in ADPKD — Rochester, Minnesota
• Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) — Rochester, Minnesota

Explore by condition: All Autosomal Dominant Polycystic Kidney Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.